兴齐眼药
(300573)
| 流通市值：98.68亿 | | | 总市值：128.76亿 |
| 流通股本：2.72亿 | | | 总股本：3.55亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,237,615,141 | 1,400,873,956.41 | 683,337,441.58 | 2,472,852,236.79 |
| 营业总成本 | 1,420,647,591.28 | 921,296,880.83 | 456,989,442.88 | 1,667,470,697.01 |
| 其他经营收益 | | | | |
| 营业利润 | 833,807,248.74 | 495,015,152.24 | 232,577,701.6 | 822,222,229.31 |
| 利润总额 | 807,046,619.09 | 482,298,715.46 | 230,119,426.69 | 800,275,673.72 |
| 净利润 | 705,105,856.98 | 430,404,293.36 | 206,414,274.49 | 695,855,596.25 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | 1,416,666.67 |
| 综合收益总额 | 705,105,856.98 | 430,404,293.36 | 206,414,274.49 | 697,272,262.92 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,140,755,490.58 | 1,014,206,648.5 | 1,132,738,018.18 | 930,732,444.32 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,854,220,934.83 | 1,729,079,064.95 | 1,616,181,869.2 | 1,608,245,264.41 |
| 资产总计 | 2,994,976,425.41 | 2,743,285,713.45 | 2,748,919,887.38 | 2,538,977,708.73 |
| 流动负债: | | | | |
| 流动负债合计 | 604,012,796.65 | 519,037,043.81 | 506,954,378.26 | 500,828,711.55 |
| 非流动负债: | | | | |
| 非流动负债合计 | 159,447,269.22 | 61,211,011.81 | 56,860,813.57 | 60,101,928.1 |
| 负债合计 | 763,460,065.87 | 580,248,055.62 | 563,815,191.83 | 560,930,639.65 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,231,516,359.54 | 2,163,037,657.83 | 2,185,104,695.55 | 1,978,047,069.08 |
| 股东权益合计 | 2,231,516,359.54 | 2,163,037,657.83 | 2,185,104,695.55 | 1,978,047,069.08 |
| 负债和股东权益合计 | 2,994,976,425.41 | 2,743,285,713.45 | 2,748,919,887.38 | 2,538,977,708.73 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,242,620,835.36 | 1,402,417,586.33 | 679,067,444.5 | 2,457,587,752.47 |
| 经营活动现金流出小计 | 1,530,085,134.67 | 1,008,970,972.83 | 470,620,045.06 | 1,704,198,966.79 |
| 经营活动产生的现金流量净额 | 712,535,700.69 | 393,446,613.5 | 208,447,399.44 | 753,388,785.68 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 766,486.14 | -620,947.49 | - | 4,681,632.36 |
| 投资活动现金流出小计 | 139,244,260.9 | 61,999,343.6 | 27,037,575.12 | 274,417,530.99 |
| 投资活动产生的现金流量净额 | -138,477,774.76 | -62,620,291.09 | -27,037,575.12 | -269,735,898.63 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 149,500,000 | 60,500,000 | - | 237,521,731.49 |
| 筹资活动现金流出小计 | 581,154,106.07 | 320,494,804.47 | 1,999,636.26 | 695,912,830.95 |
| 筹资活动产生的现金流量净额 | -431,654,106.07 | -259,994,804.47 | -1,999,636.26 | -458,391,099.46 |
| 汇率变动对现金及现金等价物的影响 | 1,702,506.69 | 1,702,119.61 | 907,818.63 | -1,669,055.28 |
| 现金及现金等价物净增加额 | 144,106,326.55 | 72,533,637.55 | 180,318,006.69 | 23,592,732.31 |
| 期末现金及现金等价物余额 | 530,536,241.82 | 458,963,552.82 | 566,747,921.96 | 386,429,915.27 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 72,533,637.55 | - | 23,592,732.31 |
最新报告期：2026-09-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国投证券 | 冯俊曦 | 2.65 | 3.57 | 4.66 | 2026-09-08 |
| 开源证券 | 余汝意 | 2.75 | 3.70 | 5.04 | 2026-08-29 |